In some cases, high expression of YY1 correlated with poor prognosis (such as in prostate, breast and bone cancers) [10,13,20], whereas in other situations, YY1 expression correlated with favorable outcomes (such as in ovarian cancer, colon cancer and follicular lymphoma) [11,12,21]. This evidence concerns the gene YY1 and ovarian carcinoma.